A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease

Peterson LB., Bell CJM., Howlett SK., Pekalski ML., Brady K., Hinton H., Sauter D., Todd JA., Umana P., Ast O., Waldhauer I., Freimoser-Grundschober A., Moessner E., Klein C., Hosse RJ., Wicker LS.

DOI

10.1016/j.jaut.2018.10.017

Type

Journal article

Journal

Journal of Autoimmunity

Publisher

Elsevier BV

Publication Date

12/2018

Volume

95

Pages

1 - 14

Permalink Original publication